If you have the training and competency, its entirely ethicalespecially when obesity and mental health intersect (medication-induced weight gain, binge eating disorder, depression worsening from metabolic issues)
Current Manufacturing Challenges The production of GLP-1RAs like semaglutide begins with the culturing of Saccharomyces cerevisiae yeast cells engineered to produce GLP-1
The rapid expansion of the market is primarily attributed to the increasing prevalence of type 2 diabetes and obesity, a growing aging population, changing lifestyle patterns, and the continuous development of advanced GLP-1 formulations, including oral therapies and long-acting injectable drugs
doi: 10.18632/oncotarget.7839 17 AngellTELechnerMGJangJKCorreaAJLoPrestiJSEpsteinAL
At SOF Week 2026, Regina Gina Sims, Director of the Department of Wars (DoW) Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Program Office under the Undersecretary of Defense for Research and Engineering, briefed on the programs reauthorization, structural overhaul and new funding mechanisms